FDA Drug Information Updates
Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.
16
Episodes 1-8 of 8
- FDA Drug Information Updates
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
- FDA Drug Information Updates
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
- FDA Drug Information Updates
FDA Review: Adding LABAs to ICS Treatment Does Not Significantly Increase Serious Asthma Outcomes Risk
Leonard H. Calabrese, DO
John R. Tesser, MD
